Skip to main content

Home

  • Home
  • Hot
  • New
  • Opinions
  • Media
    • The Times of Israel
    • The Yeshiva World
    • Voz Iz Neias
    • Matzav
  • Home
  • New Israeli technology improves prediction of patient response to immunotherapy
07 Jun

New Israeli technology improves prediction of patient response to immunotherapy

By admin 0 Comments

Ben-Gurion University researchers develop innovative biosensor, team up with Israeli biotech company OncoHost in bid for FDA approval

Details
Vote up!
Vote down!

Points: -39

Category: 
Israel Inside
Ben-Gurion University of the Negev (BGU)
immunotherapy
T cells
immune system
cancer
ONCOHOST
US Food and Drug Administration (FDA)
proteins
  • Log in or register to post comments

Author

anon

admin

Hot

  • Colorado Terror Suspect Ranted ‘God Is Greater’ Than America In Video Before Antisemitic Firebomb Attack
  • Singing “Acheinu” Neilas HaChag At The Kever Of The Baal Shem Tov In Mezibuz
  • Assemblyman Avi Schnall Updates on Push for Historic National Tax Credit for Jewish and Private Schools

User login

  • Create new account
  • Request new password

Recent comments

No comments available.